🇺🇸 FDA
Patent

US 10611744

Highly purified pharmaceutical grade tasimelteon

granted A61PA61P25/20

Quick answer

US patent 10611744 (Highly purified pharmaceutical grade tasimelteon) held by VANDA PHARMACEUTICALS INC. expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P25/20